Werum PAS-X MES enables you to digitally and automatically manage your entire production process, needle to needle, for cell and gene therapies. That way, your manufacturing operations are faster, more reliable and compliant.
As a manufacturer of cell therapies, you face extraordinary challenges due to the highly complex nature of the manufacturing processes of regenerative medicines including cell therapies, gene therapies and stem cell therapies. The manufacturing execution system Werum PAS-X MES enables you to digitally manage and control your production processes efficiently and flawlessly — from the time the personalized tailored medication is ordered, to its manufacture and the dispatch logistics, and finally, to its use and the subsequent examination and infusion of the drug to the patient.
At the same time, Werum PAS-X MES enables you to manage volumes of data when many patients are involved. You guarantee that the donated cells and the medication derived from them are uniquely assigned to patients during the entire process (chain of identity). This ensures that every patient receives his or her individually personalized medicine as quickly as possible. All events along the value chain are recorded during the entire process (chain of custody). Each and every member who is part of the process gets logged (chain of compliance).